nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP19A1—Paclitaxel—kidney cancer	0.142	0.223	CbGbCtD
Anastrozole—CYP3A4—Everolimus—kidney cancer	0.0777	0.122	CbGbCtD
Anastrozole—CYP1A2—Pazopanib—kidney cancer	0.0526	0.0827	CbGbCtD
Anastrozole—CYP3A4—Temsirolimus—kidney cancer	0.0525	0.0825	CbGbCtD
Anastrozole—CYP2C9—Capecitabine—kidney cancer	0.0494	0.0777	CbGbCtD
Anastrozole—CYP1A2—Erlotinib—kidney cancer	0.0375	0.059	CbGbCtD
Anastrozole—CYP2C9—Paclitaxel—kidney cancer	0.031	0.0487	CbGbCtD
Anastrozole—CYP1A2—Sorafenib—kidney cancer	0.0305	0.048	CbGbCtD
Anastrozole—CYP3A4—Pazopanib—kidney cancer	0.0276	0.0433	CbGbCtD
Anastrozole—CYP2C9—Sorafenib—kidney cancer	0.0275	0.0432	CbGbCtD
Anastrozole—CYP3A4—Erlotinib—kidney cancer	0.0197	0.0309	CbGbCtD
Anastrozole—CYP3A4—Paclitaxel—kidney cancer	0.018	0.0283	CbGbCtD
Anastrozole—CYP3A4—Sorafenib—kidney cancer	0.016	0.0251	CbGbCtD
Anastrozole—CYP3A4—Vinblastine—kidney cancer	0.0158	0.0248	CbGbCtD
Anastrozole—CYP3A4—Vincristine—kidney cancer	0.0155	0.0244	CbGbCtD
Anastrozole—CYP3A4—Sunitinib—kidney cancer	0.013	0.0204	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—kidney cancer	0.0097	0.0153	CbGbCtD
Anastrozole—Vomiting—Vinblastine—kidney cancer	0.000177	0.000536	CcSEcCtD
Anastrozole—Dizziness—Erlotinib—kidney cancer	0.000177	0.000536	CcSEcCtD
Anastrozole—Ill-defined disorder—Paclitaxel—kidney cancer	0.000177	0.000536	CcSEcCtD
Anastrozole—Vomiting—Everolimus—kidney cancer	0.000177	0.000534	CcSEcCtD
Anastrozole—Anaemia—Paclitaxel—kidney cancer	0.000177	0.000534	CcSEcCtD
Anastrozole—Paraesthesia—Vincristine—kidney cancer	0.000176	0.000533	CcSEcCtD
Anastrozole—Dermatitis bullous—Doxorubicin—kidney cancer	0.000176	0.000531	CcSEcCtD
Anastrozole—Rash—Everolimus—kidney cancer	0.000175	0.00053	CcSEcCtD
Anastrozole—Dermatitis—Everolimus—kidney cancer	0.000175	0.000529	CcSEcCtD
Anastrozole—Headache—Vinblastine—kidney cancer	0.000175	0.000528	CcSEcCtD
Anastrozole—Angioedema—Paclitaxel—kidney cancer	0.000175	0.000528	CcSEcCtD
Anastrozole—Headache—Everolimus—kidney cancer	0.000174	0.000526	CcSEcCtD
Anastrozole—Body temperature increased—Dactinomycin—kidney cancer	0.000174	0.000525	CcSEcCtD
Anastrozole—Abdominal pain—Dactinomycin—kidney cancer	0.000174	0.000525	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000173	0.000524	CcSEcCtD
Anastrozole—Asthenia—Sorafenib—kidney cancer	0.000173	0.000523	CcSEcCtD
Anastrozole—Malaise—Paclitaxel—kidney cancer	0.000172	0.000521	CcSEcCtD
Anastrozole—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000171	0.000518	CcSEcCtD
Anastrozole—Lethargy—Doxorubicin—kidney cancer	0.000171	0.000518	CcSEcCtD
Anastrozole—Leukopenia—Paclitaxel—kidney cancer	0.000171	0.000517	CcSEcCtD
Anastrozole—Hypersensitivity—Sunitinib—kidney cancer	0.000171	0.000517	CcSEcCtD
Anastrozole—Decreased appetite—Vincristine—kidney cancer	0.000171	0.000516	CcSEcCtD
Anastrozole—Pruritus—Sorafenib—kidney cancer	0.000171	0.000516	CcSEcCtD
Anastrozole—Vomiting—Erlotinib—kidney cancer	0.000171	0.000515	CcSEcCtD
Anastrozole—Erythema multiforme—Capecitabine—kidney cancer	0.00017	0.000515	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00017	0.000513	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Vincristine—kidney cancer	0.00017	0.000512	CcSEcCtD
Anastrozole—Fatigue—Vincristine—kidney cancer	0.000169	0.000512	CcSEcCtD
Anastrozole—Rash—Erlotinib—kidney cancer	0.000169	0.000511	CcSEcCtD
Anastrozole—Dermatitis—Erlotinib—kidney cancer	0.000169	0.000511	CcSEcCtD
Anastrozole—Insomnia—Gemcitabine—kidney cancer	0.000168	0.000509	CcSEcCtD
Anastrozole—Headache—Erlotinib—kidney cancer	0.000168	0.000508	CcSEcCtD
Anastrozole—Pain—Vincristine—kidney cancer	0.000168	0.000508	CcSEcCtD
Anastrozole—Constipation—Vincristine—kidney cancer	0.000168	0.000508	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—kidney cancer	0.000168	0.000507	CcSEcCtD
Anastrozole—Paraesthesia—Gemcitabine—kidney cancer	0.000167	0.000506	CcSEcCtD
Anastrozole—Cough—Paclitaxel—kidney cancer	0.000167	0.000504	CcSEcCtD
Anastrozole—Asthenia—Sunitinib—kidney cancer	0.000167	0.000504	CcSEcCtD
Anastrozole—Dyspnoea—Gemcitabine—kidney cancer	0.000166	0.000502	CcSEcCtD
Anastrozole—Nausea—Vinblastine—kidney cancer	0.000166	0.000501	CcSEcCtD
Anastrozole—Somnolence—Gemcitabine—kidney cancer	0.000166	0.000501	CcSEcCtD
Anastrozole—Nausea—Everolimus—kidney cancer	0.000165	0.000499	CcSEcCtD
Anastrozole—Diarrhoea—Sorafenib—kidney cancer	0.000165	0.000499	CcSEcCtD
Anastrozole—Hypertension—Paclitaxel—kidney cancer	0.000165	0.000499	CcSEcCtD
Anastrozole—Pruritus—Sunitinib—kidney cancer	0.000164	0.000497	CcSEcCtD
Anastrozole—Chest pain—Paclitaxel—kidney cancer	0.000163	0.000492	CcSEcCtD
Anastrozole—Arthralgia—Paclitaxel—kidney cancer	0.000163	0.000492	CcSEcCtD
Anastrozole—Myalgia—Paclitaxel—kidney cancer	0.000163	0.000492	CcSEcCtD
Anastrozole—Anxiety—Paclitaxel—kidney cancer	0.000162	0.00049	CcSEcCtD
Anastrozole—Decreased appetite—Gemcitabine—kidney cancer	0.000162	0.00049	CcSEcCtD
Anastrozole—Hypersensitivity—Dactinomycin—kidney cancer	0.000162	0.00049	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000161	0.000486	CcSEcCtD
Anastrozole—Discomfort—Paclitaxel—kidney cancer	0.000161	0.000486	CcSEcCtD
Anastrozole—Fatigue—Gemcitabine—kidney cancer	0.000161	0.000486	CcSEcCtD
Anastrozole—Gastrointestinal pain—Vincristine—kidney cancer	0.000161	0.000485	CcSEcCtD
Anastrozole—Dizziness—Sorafenib—kidney cancer	0.00016	0.000482	CcSEcCtD
Anastrozole—Constipation—Gemcitabine—kidney cancer	0.000159	0.000482	CcSEcCtD
Anastrozole—Pain—Gemcitabine—kidney cancer	0.000159	0.000482	CcSEcCtD
Anastrozole—Nausea—Erlotinib—kidney cancer	0.000159	0.000482	CcSEcCtD
Anastrozole—Alopecia—Capecitabine—kidney cancer	0.000159	0.000481	CcSEcCtD
Anastrozole—Dry mouth—Paclitaxel—kidney cancer	0.000159	0.000481	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—kidney cancer	0.000159	0.000481	CcSEcCtD
Anastrozole—Diarrhoea—Sunitinib—kidney cancer	0.000159	0.00048	CcSEcCtD
Anastrozole—Asthenia—Dactinomycin—kidney cancer	0.000158	0.000477	CcSEcCtD
Anastrozole—Confusional state—Paclitaxel—kidney cancer	0.000157	0.000475	CcSEcCtD
Anastrozole—Erythema—Capecitabine—kidney cancer	0.000157	0.000474	CcSEcCtD
Anastrozole—Oedema—Paclitaxel—kidney cancer	0.000156	0.000471	CcSEcCtD
Anastrozole—Anaphylactic shock—Paclitaxel—kidney cancer	0.000156	0.000471	CcSEcCtD
Anastrozole—Abdominal pain—Vincristine—kidney cancer	0.000155	0.000469	CcSEcCtD
Anastrozole—Body temperature increased—Vincristine—kidney cancer	0.000155	0.000469	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—kidney cancer	0.000155	0.000468	CcSEcCtD
Anastrozole—Infection—Paclitaxel—kidney cancer	0.000155	0.000468	CcSEcCtD
Anastrozole—Dysgeusia—Capecitabine—kidney cancer	0.000154	0.000464	CcSEcCtD
Anastrozole—Dizziness—Sunitinib—kidney cancer	0.000154	0.000464	CcSEcCtD
Anastrozole—Feeling abnormal—Gemcitabine—kidney cancer	0.000154	0.000464	CcSEcCtD
Anastrozole—Vomiting—Sorafenib—kidney cancer	0.000153	0.000464	CcSEcCtD
Anastrozole—Rash—Sorafenib—kidney cancer	0.000152	0.00046	CcSEcCtD
Anastrozole—Dermatitis—Sorafenib—kidney cancer	0.000152	0.000459	CcSEcCtD
Anastrozole—Back pain—Capecitabine—kidney cancer	0.000152	0.000459	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000151	0.000457	CcSEcCtD
Anastrozole—Headache—Sorafenib—kidney cancer	0.000151	0.000457	CcSEcCtD
Anastrozole—Hyperhidrosis—Paclitaxel—kidney cancer	0.000151	0.000456	CcSEcCtD
Anastrozole—Diarrhoea—Dactinomycin—kidney cancer	0.00015	0.000455	CcSEcCtD
Anastrozole—Anorexia—Paclitaxel—kidney cancer	0.000149	0.000449	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000148	0.000448	CcSEcCtD
Anastrozole—Vomiting—Sunitinib—kidney cancer	0.000148	0.000446	CcSEcCtD
Anastrozole—Body temperature increased—Gemcitabine—kidney cancer	0.000147	0.000445	CcSEcCtD
Anastrozole—Rash—Sunitinib—kidney cancer	0.000146	0.000443	CcSEcCtD
Anastrozole—Dermatitis—Sunitinib—kidney cancer	0.000146	0.000442	CcSEcCtD
Anastrozole—Ill-defined disorder—Capecitabine—kidney cancer	0.000146	0.00044	CcSEcCtD
Anastrozole—Headache—Sunitinib—kidney cancer	0.000145	0.00044	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—kidney cancer	0.000145	0.000439	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—kidney cancer	0.000145	0.000439	CcSEcCtD
Anastrozole—Anaemia—Capecitabine—kidney cancer	0.000145	0.000438	CcSEcCtD
Anastrozole—Hypersensitivity—Vincristine—kidney cancer	0.000145	0.000437	CcSEcCtD
Anastrozole—Nausea—Sorafenib—kidney cancer	0.000143	0.000433	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000142	0.00043	CcSEcCtD
Anastrozole—Malaise—Capecitabine—kidney cancer	0.000141	0.000428	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—kidney cancer	0.000141	0.000427	CcSEcCtD
Anastrozole—Insomnia—Paclitaxel—kidney cancer	0.000141	0.000426	CcSEcCtD
Anastrozole—Asthenia—Vincristine—kidney cancer	0.000141	0.000426	CcSEcCtD
Anastrozole—Leukopenia—Capecitabine—kidney cancer	0.00014	0.000424	CcSEcCtD
Anastrozole—Paraesthesia—Paclitaxel—kidney cancer	0.00014	0.000423	CcSEcCtD
Anastrozole—Vomiting—Dactinomycin—kidney cancer	0.00014	0.000422	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—kidney cancer	0.00014	0.000422	CcSEcCtD
Anastrozole—Dyspnoea—Paclitaxel—kidney cancer	0.000139	0.00042	CcSEcCtD
Anastrozole—Somnolence—Paclitaxel—kidney cancer	0.000139	0.000419	CcSEcCtD
Anastrozole—Rash—Dactinomycin—kidney cancer	0.000139	0.000419	CcSEcCtD
Anastrozole—Nausea—Sunitinib—kidney cancer	0.000138	0.000417	CcSEcCtD
Anastrozole—Dyspepsia—Paclitaxel—kidney cancer	0.000137	0.000415	CcSEcCtD
Anastrozole—Cough—Capecitabine—kidney cancer	0.000137	0.000414	CcSEcCtD
Anastrozole—Decreased appetite—Paclitaxel—kidney cancer	0.000136	0.00041	CcSEcCtD
Anastrozole—Hypertension—Capecitabine—kidney cancer	0.000135	0.000409	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000135	0.000407	CcSEcCtD
Anastrozole—Fatigue—Paclitaxel—kidney cancer	0.000134	0.000406	CcSEcCtD
Anastrozole—Diarrhoea—Vincristine—kidney cancer	0.000134	0.000406	CcSEcCtD
Anastrozole—Asthenia—Gemcitabine—kidney cancer	0.000134	0.000404	CcSEcCtD
Anastrozole—Arthralgia—Capecitabine—kidney cancer	0.000134	0.000404	CcSEcCtD
Anastrozole—Myalgia—Capecitabine—kidney cancer	0.000134	0.000404	CcSEcCtD
Anastrozole—Chest pain—Capecitabine—kidney cancer	0.000134	0.000404	CcSEcCtD
Anastrozole—Pain—Paclitaxel—kidney cancer	0.000133	0.000403	CcSEcCtD
Anastrozole—Constipation—Paclitaxel—kidney cancer	0.000133	0.000403	CcSEcCtD
Anastrozole—Anxiety—Capecitabine—kidney cancer	0.000133	0.000402	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—kidney cancer	0.000132	0.000399	CcSEcCtD
Anastrozole—Discomfort—Capecitabine—kidney cancer	0.000132	0.000399	CcSEcCtD
Anastrozole—Pruritus—Gemcitabine—kidney cancer	0.000132	0.000398	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—kidney cancer	0.000131	0.000397	CcSEcCtD
Anastrozole—Dry mouth—Capecitabine—kidney cancer	0.000131	0.000395	CcSEcCtD
Anastrozole—Nausea—Dactinomycin—kidney cancer	0.000131	0.000395	CcSEcCtD
Anastrozole—Dizziness—Vincristine—kidney cancer	0.00013	0.000393	CcSEcCtD
Anastrozole—Confusional state—Capecitabine—kidney cancer	0.000129	0.00039	CcSEcCtD
Anastrozole—Feeling abnormal—Paclitaxel—kidney cancer	0.000129	0.000389	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000128	0.000388	CcSEcCtD
Anastrozole—Oedema—Capecitabine—kidney cancer	0.000128	0.000387	CcSEcCtD
Anastrozole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000128	0.000386	CcSEcCtD
Anastrozole—Diarrhoea—Gemcitabine—kidney cancer	0.000127	0.000385	CcSEcCtD
Anastrozole—Infection—Capecitabine—kidney cancer	0.000127	0.000384	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000127	0.000383	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—kidney cancer	0.000126	0.000381	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—kidney cancer	0.000126	0.00038	CcSEcCtD
Anastrozole—Vomiting—Vincristine—kidney cancer	0.000125	0.000377	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—kidney cancer	0.000124	0.000375	CcSEcCtD
Anastrozole—Urticaria—Paclitaxel—kidney cancer	0.000124	0.000375	CcSEcCtD
Anastrozole—Rash—Vincristine—kidney cancer	0.000124	0.000374	CcSEcCtD
Anastrozole—Hyperhidrosis—Capecitabine—kidney cancer	0.000124	0.000374	CcSEcCtD
Anastrozole—Dermatitis—Vincristine—kidney cancer	0.000124	0.000374	CcSEcCtD
Anastrozole—Abdominal pain—Paclitaxel—kidney cancer	0.000123	0.000373	CcSEcCtD
Anastrozole—Body temperature increased—Paclitaxel—kidney cancer	0.000123	0.000373	CcSEcCtD
Anastrozole—Headache—Vincristine—kidney cancer	0.000123	0.000372	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000122	0.00037	CcSEcCtD
Anastrozole—Anorexia—Capecitabine—kidney cancer	0.000122	0.000369	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—kidney cancer	0.000121	0.000367	CcSEcCtD
Anastrozole—Vomiting—Gemcitabine—kidney cancer	0.000118	0.000358	CcSEcCtD
Anastrozole—Rash—Gemcitabine—kidney cancer	0.000117	0.000355	CcSEcCtD
Anastrozole—Dermatitis—Gemcitabine—kidney cancer	0.000117	0.000355	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—kidney cancer	0.000117	0.000353	CcSEcCtD
Anastrozole—Headache—Gemcitabine—kidney cancer	0.000117	0.000353	CcSEcCtD
Anastrozole—Nausea—Vincristine—kidney cancer	0.000117	0.000353	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000117	0.000353	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—kidney cancer	0.000116	0.000352	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—kidney cancer	0.000116	0.000351	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—kidney cancer	0.000116	0.000351	CcSEcCtD
Anastrozole—Insomnia—Capecitabine—kidney cancer	0.000116	0.00035	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—kidney cancer	0.000115	0.000348	CcSEcCtD
Anastrozole—Paraesthesia—Capecitabine—kidney cancer	0.000115	0.000347	CcSEcCtD
Anastrozole—Hypersensitivity—Paclitaxel—kidney cancer	0.000115	0.000347	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—kidney cancer	0.000114	0.000346	CcSEcCtD
Anastrozole—Dyspnoea—Capecitabine—kidney cancer	0.000114	0.000345	CcSEcCtD
Anastrozole—Dyspepsia—Capecitabine—kidney cancer	0.000113	0.000341	CcSEcCtD
Anastrozole—Asthenia—Paclitaxel—kidney cancer	0.000112	0.000338	CcSEcCtD
Anastrozole—Decreased appetite—Capecitabine—kidney cancer	0.000111	0.000336	CcSEcCtD
Anastrozole—Nausea—Gemcitabine—kidney cancer	0.000111	0.000334	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00011	0.000334	CcSEcCtD
Anastrozole—Fatigue—Capecitabine—kidney cancer	0.00011	0.000334	CcSEcCtD
Anastrozole—Pruritus—Paclitaxel—kidney cancer	0.00011	0.000334	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—kidney cancer	0.00011	0.000332	CcSEcCtD
Anastrozole—Pain—Capecitabine—kidney cancer	0.000109	0.000331	CcSEcCtD
Anastrozole—Constipation—Capecitabine—kidney cancer	0.000109	0.000331	CcSEcCtD
Anastrozole—Diarrhoea—Paclitaxel—kidney cancer	0.000107	0.000323	CcSEcCtD
Anastrozole—Feeling abnormal—Capecitabine—kidney cancer	0.000105	0.000319	CcSEcCtD
Anastrozole—Gastrointestinal pain—Capecitabine—kidney cancer	0.000105	0.000316	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	0.000104	0.00313	CbGpPWpGaD
Anastrozole—Dizziness—Paclitaxel—kidney cancer	0.000103	0.000312	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—kidney cancer	0.000103	0.00031	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	0.000103	0.00308	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	0.000102	0.00307	CbGpPWpGaD
Anastrozole—Urticaria—Capecitabine—kidney cancer	0.000102	0.000307	CcSEcCtD
Anastrozole—Body temperature increased—Capecitabine—kidney cancer	0.000101	0.000306	CcSEcCtD
Anastrozole—Abdominal pain—Capecitabine—kidney cancer	0.000101	0.000306	CcSEcCtD
Anastrozole—CYP19A1—Biological oxidations—GSTM1—kidney cancer	0.000101	0.00304	CbGpPWpGaD
Anastrozole—Erythema—Doxorubicin—kidney cancer	0.000101	0.000306	CcSEcCtD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTM1—kidney cancer	9.97e-05	0.00299	CbGpPWpGaD
Anastrozole—Tension—Doxorubicin—kidney cancer	9.92e-05	0.0003	CcSEcCtD
Anastrozole—Vomiting—Paclitaxel—kidney cancer	9.92e-05	0.0003	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—kidney cancer	9.9e-05	0.000299	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.85e-05	0.00296	CbGpPWpGaD
Anastrozole—Rash—Paclitaxel—kidney cancer	9.83e-05	0.000297	CcSEcCtD
Anastrozole—Dermatitis—Paclitaxel—kidney cancer	9.82e-05	0.000297	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—kidney cancer	9.82e-05	0.000297	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—kidney cancer	9.78e-05	0.000296	CcSEcCtD
Anastrozole—Headache—Paclitaxel—kidney cancer	9.77e-05	0.000295	CcSEcCtD
Anastrozole—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	9.74e-05	0.00292	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.72e-05	0.00292	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP1A1—kidney cancer	9.59e-05	0.00288	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP1A1—kidney cancer	9.45e-05	0.00284	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	9.43e-05	0.00283	CbGpPWpGaD
Anastrozole—Hypersensitivity—Capecitabine—kidney cancer	9.43e-05	0.000285	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—kidney cancer	9.38e-05	0.000284	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—kidney cancer	9.34e-05	0.000282	CcSEcCtD
Anastrozole—Nausea—Paclitaxel—kidney cancer	9.26e-05	0.00028	CcSEcCtD
Anastrozole—Asthenia—Capecitabine—kidney cancer	9.18e-05	0.000278	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—kidney cancer	9.12e-05	0.000276	CcSEcCtD
Anastrozole—Pruritus—Capecitabine—kidney cancer	9.06e-05	0.000274	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—kidney cancer	9.05e-05	0.000274	CcSEcCtD
Anastrozole—Cough—Doxorubicin—kidney cancer	8.82e-05	0.000267	CcSEcCtD
Anastrozole—Diarrhoea—Capecitabine—kidney cancer	8.76e-05	0.000265	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—kidney cancer	8.73e-05	0.000264	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—kidney cancer	8.61e-05	0.00026	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—kidney cancer	8.61e-05	0.00026	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—kidney cancer	8.61e-05	0.00026	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—kidney cancer	8.58e-05	0.000259	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—kidney cancer	8.5e-05	0.000257	CcSEcCtD
Anastrozole—Dizziness—Capecitabine—kidney cancer	8.46e-05	0.000256	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—ACY1—kidney cancer	8.43e-05	0.00253	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.42e-05	0.00253	CbGpPWpGaD
Anastrozole—Dry mouth—Doxorubicin—kidney cancer	8.42e-05	0.000254	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—kidney cancer	8.32e-05	0.000251	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.31e-05	0.00249	CbGpPWpGaD
Anastrozole—Anaphylactic shock—Doxorubicin—kidney cancer	8.25e-05	0.000249	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—kidney cancer	8.25e-05	0.000249	CcSEcCtD
Anastrozole—Infection—Doxorubicin—kidney cancer	8.2e-05	0.000248	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.17e-05	0.00245	CbGpPWpGaD
Anastrozole—Vomiting—Capecitabine—kidney cancer	8.14e-05	0.000246	CcSEcCtD
Anastrozole—Rash—Capecitabine—kidney cancer	8.07e-05	0.000244	CcSEcCtD
Anastrozole—Dermatitis—Capecitabine—kidney cancer	8.06e-05	0.000244	CcSEcCtD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.03e-05	0.00241	CbGpPWpGaD
Anastrozole—Headache—Capecitabine—kidney cancer	8.02e-05	0.000242	CcSEcCtD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.98e-05	0.0024	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Doxorubicin—kidney cancer	7.98e-05	0.000241	CcSEcCtD
Anastrozole—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	7.88e-05	0.00237	CbGpPWpGaD
Anastrozole—Anorexia—Doxorubicin—kidney cancer	7.86e-05	0.000238	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	7.83e-05	0.00235	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	7.67e-05	0.0023	CbGpPWpGaD
Anastrozole—Nausea—Capecitabine—kidney cancer	7.6e-05	0.00023	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.52e-05	0.000227	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—kidney cancer	7.46e-05	0.000226	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—kidney cancer	7.41e-05	0.000224	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—kidney cancer	7.36e-05	0.000222	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.34e-05	0.0022	CbGpPWpGaD
Anastrozole—Somnolence—Doxorubicin—kidney cancer	7.33e-05	0.000222	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—kidney cancer	7.26e-05	0.00022	CcSEcCtD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.19e-05	0.00216	CbGpPWpGaD
Anastrozole—Decreased appetite—Doxorubicin—kidney cancer	7.17e-05	0.000217	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—PDHB—kidney cancer	7.17e-05	0.00215	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—POMC—kidney cancer	7.15e-05	0.00215	CbGpPWpGaD
Anastrozole—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.12e-05	0.000215	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—kidney cancer	7.11e-05	0.000215	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	7.11e-05	0.00214	CbGpPWpGaD
Anastrozole—Constipation—Doxorubicin—kidney cancer	7.06e-05	0.000213	CcSEcCtD
Anastrozole—Pain—Doxorubicin—kidney cancer	7.06e-05	0.000213	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—GSTT1—kidney cancer	7.02e-05	0.00211	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.82e-05	0.00205	CbGpPWpGaD
Anastrozole—Feeling abnormal—Doxorubicin—kidney cancer	6.8e-05	0.000206	CcSEcCtD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	6.78e-05	0.00203	CbGpPWpGaD
Anastrozole—Gastrointestinal pain—Doxorubicin—kidney cancer	6.75e-05	0.000204	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—CCBL1—kidney cancer	6.74e-05	0.00202	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—PTGS1—kidney cancer	6.58e-05	0.00198	CbGpPWpGaD
Anastrozole—Urticaria—Doxorubicin—kidney cancer	6.55e-05	0.000198	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	6.54e-05	0.00196	CbGpPWpGaD
Anastrozole—Abdominal pain—Doxorubicin—kidney cancer	6.52e-05	0.000197	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—kidney cancer	6.52e-05	0.000197	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.5e-05	0.00195	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.41e-05	0.00192	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	6.4e-05	0.00192	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	6.38e-05	0.00192	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	6.37e-05	0.00191	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.28e-05	0.00188	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	6.19e-05	0.00186	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.1e-05	0.00183	CbGpPWpGaD
Anastrozole—Hypersensitivity—Doxorubicin—kidney cancer	6.08e-05	0.000184	CcSEcCtD
Anastrozole—CYP1A2—Biological oxidations—GSTT1—kidney cancer	6e-05	0.0018	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.95e-05	0.00179	CbGpPWpGaD
Anastrozole—Asthenia—Doxorubicin—kidney cancer	5.92e-05	0.000179	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	5.86e-05	0.00176	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	5.86e-05	0.00176	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPAT—kidney cancer	5.84e-05	0.00175	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GLIPR1—kidney cancer	5.84e-05	0.00175	CbGpPWpGaD
Anastrozole—Pruritus—Doxorubicin—kidney cancer	5.84e-05	0.000176	CcSEcCtD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	5.81e-05	0.00174	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	5.79e-05	0.00174	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	5.77e-05	0.00173	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	5.74e-05	0.00172	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	5.72e-05	0.00172	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	5.71e-05	0.00171	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	5.7e-05	0.00171	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	5.66e-05	0.0017	CbGpPWpGaD
Anastrozole—Diarrhoea—Doxorubicin—kidney cancer	5.64e-05	0.000171	CcSEcCtD
Anastrozole—CYP1A2—Biological oxidations—PTGS1—kidney cancer	5.62e-05	0.00169	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	5.58e-05	0.00168	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	5.52e-05	0.00166	CbGpPWpGaD
Anastrozole—Dizziness—Doxorubicin—kidney cancer	5.46e-05	0.000165	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—APRT—kidney cancer	5.43e-05	0.00163	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—FH—kidney cancer	5.43e-05	0.00163	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.31e-05	0.00159	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.27e-05	0.00158	CbGpPWpGaD
Anastrozole—Vomiting—Doxorubicin—kidney cancer	5.25e-05	0.000159	CcSEcCtD
Anastrozole—Rash—Doxorubicin—kidney cancer	5.2e-05	0.000157	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—kidney cancer	5.2e-05	0.000157	CcSEcCtD
Anastrozole—Headache—Doxorubicin—kidney cancer	5.17e-05	0.000156	CcSEcCtD
Anastrozole—CYP19A1—Metabolism—GPC3—kidney cancer	5.11e-05	0.00153	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.09e-05	0.00153	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	4.98e-05	0.0015	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CA2—kidney cancer	4.97e-05	0.00149	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.96e-05	0.00149	CbGpPWpGaD
Anastrozole—Nausea—Doxorubicin—kidney cancer	4.9e-05	0.000148	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	4.88e-05	0.00146	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTP1—kidney cancer	4.87e-05	0.00146	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.84e-05	0.00145	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALAD—kidney cancer	4.84e-05	0.00145	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	4.8e-05	0.00144	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ST3GAL2—kidney cancer	4.73e-05	0.00142	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.63e-05	0.00139	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALDH1A1—kidney cancer	4.62e-05	0.00139	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	4.58e-05	0.00138	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	4.49e-05	0.00135	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	4.49e-05	0.00135	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTM1—kidney cancer	4.47e-05	0.00134	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PGK1—kidney cancer	4.43e-05	0.00133	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC5A3—kidney cancer	4.43e-05	0.00133	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	4.41e-05	0.00132	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	4.39e-05	0.00132	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—LDHB—kidney cancer	4.34e-05	0.0013	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.34e-05	0.0013	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	4.24e-05	0.00127	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	4.24e-05	0.00127	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	4.18e-05	0.00126	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTP1—kidney cancer	4.16e-05	0.00125	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	4.15e-05	0.00124	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	4.1e-05	0.00123	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.93e-05	0.00118	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTM1—kidney cancer	3.82e-05	0.00115	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	3.77e-05	0.00113	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CA9—kidney cancer	3.77e-05	0.00113	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	3.77e-05	0.00113	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ACY1—kidney cancer	3.73e-05	0.00112	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.68e-05	0.00111	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	3.62e-05	0.00109	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.57e-05	0.00107	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.21e-05	0.000964	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CRABP1—kidney cancer	3.2e-05	0.000961	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ACY1—kidney cancer	3.19e-05	0.000957	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.18e-05	0.000955	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PDHB—kidney cancer	3.17e-05	0.000952	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.17e-05	0.000951	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—POMC—kidney cancer	3.16e-05	0.000949	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CCBL1—kidney cancer	2.98e-05	0.000895	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ITPR2—kidney cancer	2.98e-05	0.000894	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.95e-05	0.000886	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.91e-05	0.000874	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.8e-05	0.00084	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.76e-05	0.000828	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.74e-05	0.000824	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.72e-05	0.000816	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTT1—kidney cancer	2.71e-05	0.000815	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ACHE—kidney cancer	2.71e-05	0.000815	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PDHB—kidney cancer	2.71e-05	0.000814	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—POMC—kidney cancer	2.7e-05	0.000811	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.7e-05	0.00081	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPAT—kidney cancer	2.59e-05	0.000776	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.59e-05	0.000776	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SCARB1—kidney cancer	2.57e-05	0.000771	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.55e-05	0.000767	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CCBL1—kidney cancer	2.55e-05	0.000765	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS1—kidney cancer	2.54e-05	0.000764	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.53e-05	0.000759	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000749	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ACY1—kidney cancer	2.46e-05	0.000739	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—FH—kidney cancer	2.4e-05	0.000722	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—APRT—kidney cancer	2.4e-05	0.000722	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BCHE—kidney cancer	2.36e-05	0.00071	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.35e-05	0.000705	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC5A5—kidney cancer	2.34e-05	0.000701	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.3e-05	0.000692	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GPC3—kidney cancer	2.26e-05	0.000679	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC2A1—kidney cancer	2.26e-05	0.000677	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.21e-05	0.000663	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPAT—kidney cancer	2.21e-05	0.000663	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CA2—kidney cancer	2.2e-05	0.00066	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.19e-05	0.000657	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.18e-05	0.000655	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.16e-05	0.000648	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALAD—kidney cancer	2.14e-05	0.000643	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PDHB—kidney cancer	2.09e-05	0.000628	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.09e-05	0.000628	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—POMC—kidney cancer	2.09e-05	0.000626	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—FH—kidney cancer	2.05e-05	0.000617	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—APRT—kidney cancer	2.05e-05	0.000617	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.04e-05	0.000614	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.01e-05	0.000603	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CCBL1—kidney cancer	1.97e-05	0.000591	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.96e-05	0.000588	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PGK1—kidney cancer	1.96e-05	0.000588	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GPC3—kidney cancer	1.93e-05	0.00058	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—LDHB—kidney cancer	1.92e-05	0.000577	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.91e-05	0.000573	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTP1—kidney cancer	1.88e-05	0.000565	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CA2—kidney cancer	1.88e-05	0.000564	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALAD—kidney cancer	1.83e-05	0.00055	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.79e-05	0.000537	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ABCB1—kidney cancer	1.78e-05	0.000535	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.75e-05	0.000524	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTM1—kidney cancer	1.73e-05	0.000519	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPAT—kidney cancer	1.71e-05	0.000512	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.71e-05	0.000512	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PGK1—kidney cancer	1.67e-05	0.000503	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.67e-05	0.000503	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CA9—kidney cancer	1.67e-05	0.0005	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—LDHB—kidney cancer	1.64e-05	0.000493	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1A1—kidney cancer	1.64e-05	0.000492	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.63e-05	0.000489	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—APRT—kidney cancer	1.59e-05	0.000476	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—FH—kidney cancer	1.59e-05	0.000476	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GPC3—kidney cancer	1.49e-05	0.000448	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CA2—kidney cancer	1.45e-05	0.000435	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CA9—kidney cancer	1.42e-05	0.000428	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CRABP1—kidney cancer	1.42e-05	0.000425	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALAD—kidney cancer	1.41e-05	0.000424	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.39e-05	0.000418	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.38e-05	0.000414	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.35e-05	0.000405	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.35e-05	0.000404	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ITPR2—kidney cancer	1.32e-05	0.000395	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PGK1—kidney cancer	1.29e-05	0.000388	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.29e-05	0.000388	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—LDHB—kidney cancer	1.27e-05	0.000381	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—POMC—kidney cancer	1.22e-05	0.000367	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.21e-05	0.000365	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CRABP1—kidney cancer	1.21e-05	0.000364	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTT1—kidney cancer	1.2e-05	0.000361	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ACHE—kidney cancer	1.2e-05	0.000361	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SCARB1—kidney cancer	1.14e-05	0.000341	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ITPR2—kidney cancer	1.13e-05	0.000338	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000338	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PSMD7—kidney cancer	1.1e-05	0.000331	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CA9—kidney cancer	1.1e-05	0.00033	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BCHE—kidney cancer	1.05e-05	0.000314	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.04e-05	0.000312	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.03e-05	0.00031	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTT1—kidney cancer	1.03e-05	0.000308	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ACHE—kidney cancer	1.03e-05	0.000308	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC2A1—kidney cancer	9.98e-06	0.0003	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—kidney cancer	9.75e-06	0.000293	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SCARB1—kidney cancer	9.72e-06	0.000292	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.69e-06	0.000291	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS1—kidney cancer	9.62e-06	0.000289	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PSMD7—kidney cancer	9.43e-06	0.000283	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CRABP1—kidney cancer	9.34e-06	0.000281	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BCHE—kidney cancer	8.94e-06	0.000268	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC5A5—kidney cancer	8.83e-06	0.000265	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ITPR2—kidney cancer	8.69e-06	0.000261	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC2A1—kidney cancer	8.53e-06	0.000256	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—kidney cancer	8.5e-06	0.000255	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.45e-06	0.000254	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—kidney cancer	8.33e-06	0.00025	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.28e-06	0.000248	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTT1—kidney cancer	7.92e-06	0.000238	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ACHE—kidney cancer	7.92e-06	0.000238	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ABCB1—kidney cancer	7.88e-06	0.000237	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTM1—kidney cancer	7.65e-06	0.00023	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SCARB1—kidney cancer	7.5e-06	0.000225	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS1—kidney cancer	7.42e-06	0.000223	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PSMD7—kidney cancer	7.28e-06	0.000219	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1A1—kidney cancer	7.25e-06	0.000218	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.22e-06	0.000217	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—kidney cancer	7.12e-06	0.000214	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BCHE—kidney cancer	6.9e-06	0.000207	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.82e-06	0.000205	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ABCB1—kidney cancer	6.74e-06	0.000202	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.58e-06	0.000198	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTM1—kidney cancer	6.54e-06	0.000196	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.2e-06	0.000186	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—kidney cancer	6e-06	0.00018	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.96e-06	0.000179	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—kidney cancer	5.49e-06	0.000165	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—POMC—kidney cancer	5.41e-06	0.000162	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ABCB1—kidney cancer	5.2e-06	0.000156	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.09e-06	0.000153	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTM1—kidney cancer	5.05e-06	0.000151	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.78e-06	0.000144	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—POMC—kidney cancer	4.62e-06	0.000139	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—kidney cancer	4.31e-06	0.00013	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—kidney cancer	3.76e-06	0.000113	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—kidney cancer	3.69e-06	0.000111	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—POMC—kidney cancer	3.57e-06	0.000107	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—kidney cancer	3.21e-06	9.65e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—kidney cancer	2.84e-06	8.54e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.65e-06	7.97e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—kidney cancer	2.48e-06	7.45e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.27e-06	6.81e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.75e-06	5.25e-05	CbGpPWpGaD
